β2-adrenoceptor Thr164Ile polymorphism is associated with markedly decreased vasodilator and increased vasoconstrictor sensitivity in vivo-Reference-Cited by-同舟云学术

β2-adrenoceptor Thr164Ile polymorphism is associated with markedly decreased vasodilator and increased vasoconstrictor sensitivity in vivo

Published:2004-08 Issue:8 Volume:14 Page:517-522
ISSN:0960-314X
Container-title:Pharmacogenetics
language:en
Short-container-title:

Author:

Dishy Victor,Landau Ruth,Sofowora Gbenga G,Xie Hong-Guang,Smiley Richard M,Kim Richard B,Byrne Daniel W,Wood Alastair JJ,Stein C Michael

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Pharmacology, Toxicology and Pharmaceutics,Genetics

Reference25 articles.

1. Mutations in the gene encoding for the beta 2-adrenergic receptor in normal and asthmatic subjects.;Reihsaus;Am J Respir Cell Mol Biol,1993

2. Frequency of a functionally important beta 2-adrenergic receptor Thr164Ile polymorphism among different ethnic groups.;Xie;Clin Pharmacol Ther,2002

3. A polymorphism of the human beta 2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor.;Green;J Biol Chem,1993

4. Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties.;Green;Biochemistry,1994

5. Myocardial signaling defects and impaired cardiac function of a human beta 2-adrenergic receptor polymorphism expressed in transgenic mice.;Turki;Proc Natl Acad Sci U S A,1996

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The physiologic response to epinephrine and pediatric cardiopulmonary resuscitation outcomes;Critical Care;2023-03-13

2. Genetic Variants of Adrenoceptors;Handbook of Experimental Pharmacology;2023

3. Rare genetic variability in human drug target genes modulates drug response and can guide precision medicine;Science Advances;2021-09-03

4. Personalized Medicine Through GPCR Pharmacogenomics;Reference Module in Biomedical Sciences;2021

5. Ligand-specific pharmacogenetic effects of nonsynonymous mutations;Pharmacogenetics and Genomics;2020-12-30